Artesunate Exploits Glutathione-Dependent Redox Vulnerability in Metastatic Lung Adenocarcinoma
Munteanu, P.; Neuhaus, S.; Feldt, P.; Serobyan, V.; Baginska, A.; Friedmann Angeli, J. P.; Becker, J.; Schramm, A.; Grüner, B. M.
Show abstract
Metastatic dissemination remains the principal cause of mortality in lung adenocarcinoma. To identify metabolic vulnerabilities associated with metastasis, we used cell lines with distinct metastatic abilities derived from the KrasG12D;p53KO mouse model. Building on evidence of mitochondrial dysfunction in metastasis-derived cells, we performed an in vivo screen of a focused metabolic drug library using a multiplexed DNA-barcoding platform. This approach identified artesunate as a selective inhibitor of metastatic seeding, which was validated in vivo to reduce metastatic burden while leaving primary tumor growth unaffected. Mechanistically, artesunate induced oxidative stress, characterized by reactive oxygen species and lipid peroxidation. Transcriptomic and mechanistic profiling revealed altered redox homeostasis in metastasis-derived cells. Inhibition of glutathione synthesis specifically sensitized these cells to artesunate, resulting in extensive cell death, whereas primary tumor-derived cells remained resistant. These findings identify glutathione-dependent redox homeostasis as a metabolic vulnerability in metastatic cells that can be specifically targeted using artesunate.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer 94%
- Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone 94%
- Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs 93%
Similar papers in this journal
- Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis 93%
- Endogenous formaldehyde scavenges cellular glutathione resulting in cytotoxic redox disruption 93%
- Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography 92%
Similar papers in this journal
Similar papers in this journal
- SLC7A11 is a superior determinant of APR-246 (Eprenetapopt) response than TP53 mutation status 94%
- Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis addicted breast tumor growth. 93%
- A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.